Management of patients with acute ischaemic stroke

被引:12
作者
Adams, HP
机构
[1] University of Iowa College of Medicine,Division of Cerebrovascular Diseases, Department of Neurology
关键词
D O I
10.2165/00003495-199700543-00010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The management of patients with acute ischaemic stroke, which was once accompanied by a sense of futility, has shifted to emergency intervention, as a result of clinical trials demonstrating the efficacy of acutely administered therapies in reducing mortality and morbidity. The current approach to stroke thus emphasises early recognition, rapid transport to hospital, speedy evaluation and urgent treatment. In the emergency room, treatment decisions are largely influenced by the neurological status of patients, although their respiratory, cardiovascular and metabolic status are also considered. Initially, efforts are aimed at reducing hypoxia and hypercarbia, controlling symptoms such as pain or vomiting, and reducing the morbidity and mortality associated with stroke. Most patients with stroke require hospitalisation; in-hospital care continues to focus on preventing and controlling subacute and chronic complications, but also includes planning for rehabilitation and care after discharge, and treatment to prevent recurrent stroke. Administration of newer treatment interventions, such as thrombolytic therapy, requires the availability of teams of stroke specialists; furthermore, the management of stroke patients in a dedicated unit has been shown to reduce death and disability and to shorten the hospital stay, While therapies aimed at reducing the neurological consequences of stroke are the keystone of current and future care. the control of acute, subacute, or chronic medical and neurological complications, prevention of recurrent stroke, and rehabilitation to maximise recovery from stroke remain crucial components of patient management.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 87 条
[71]   Hemicraniotomy in space-occupying hemispheric infarction: Useful early intervention or desperate activism? [J].
Schwab, S ;
Rieke, K ;
Aschoff, A ;
Albert, F ;
vonKummer, R ;
Hacke, W .
CEREBROVASCULAR DISEASES, 1996, 6 (06) :325-329
[72]   CEREBELLAR SOFTENING [J].
SCOTTI, G ;
SPINNLER, H ;
STERZI, R ;
VALLAR, G .
ANNALS OF NEUROLOGY, 1980, 8 (02) :133-140
[73]   ANTITHROMBOTIC THERAPY FOR CEREBROVASCULAR DISORDERS - AN UPDATE [J].
SHERMAN, DG ;
DYKEN, ML ;
GENT, M ;
HARRISON, MJG ;
HART, RG ;
MOHR, JP .
CHEST, 1995, 108 (04) :S444-S456
[74]   Population-based study of seizure disorders after cerebral infarction [J].
So, EL ;
Annegers, JF ;
Hauser, WA ;
OBrien, PC ;
Whisnant, JP .
NEUROLOGY, 1996, 46 (02) :350-355
[75]  
TAYLOR DW, 1991, NEW ENGL J MED, V325, P445
[76]   SODIUM NITROPRUSSIDE - PHARMACOLOGY, TOXICOLOGY AND THERAPEUTICS [J].
TINKER, JH ;
MICHENFELDER, JD .
ANESTHESIOLOGY, 1976, 45 (03) :340-354
[77]   A LOW-MOLECULAR-WEIGHT HEPARINOID COMPARED WITH UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH ACUTE ISCHEMIC STROKE - A RANDOMIZED, DOUBLE-BLIND-STUDY [J].
TURPIE, AGG ;
GENT, M ;
COTE, R ;
LEVINE, MN ;
GINSBERG, JS ;
POWERS, PJ ;
LECLERC, J ;
GEERTS, W ;
JAY, R ;
NEEMEH, J ;
KLIMEK, M ;
HIRSH, J .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (05) :353-357
[78]  
TURPIE AGG, 1987, LANCET, V1, P523
[79]  
VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801
[80]   DEEP VENOUS THROMBOSIS OF LEGS AFTER STROKES .1. INCIDENCE AND PREDISPOSING FACTORS [J].
WARLOW, C ;
OGSTON, D ;
DOUGLAS, AS .
BRITISH MEDICAL JOURNAL, 1976, 1 (6019) :1178-1181